Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7316 p337
11 September 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Superdrug pharmacists to offer spirometry to target COPD

Pharmacists at 20 Superdrug stores across the UK will be offering spirometry tests to about 1,000 smokers in the week of 15 November, as part of British Lung Foundation activities to mark World COPD Day.

Pharmacists will be targeting long-term smokers of 20 cigarettes or more per day, who are over 35 years. Those whose results suggest they have or are at risk of COPD will be advised to see their doctor.

The initiative will be funded by Boehringer Ingelheim and Pfizer, and the spirometers provided by Vitalograph.

The benefits of spirometry screening for symptomatic smokers were highlighted last week at the Primary Care Conference part of the European Respiratory Society meeting in Glasgow. During a 12-month spirometry screening project at a Lancashire GP practice, at least a third of 56 symptomatic smokers who were found to have significant airway obstruction quit smoking. Of those with mild COPD, 57 per cent were motivated to give up cigarettes. This compared with around a third of patients with either more severe disease or whose symptoms put them at risk of COPD, but who had normal lung function.

Kay Holt, nurse practitioner at Cleveleys Group Practice, Wyre, concluded that targeting intensive smoking cessation support at patients in the earliest stages of airway obstruction could prevent COPD or at least reduce its potential severity. She now plans to carry out a further study in local pharmacies.

Back to Top


©The Pharmaceutical Journal